Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""de Oliveira CZ"" wg kryterium: Autor


Wyświetlanie 1-18 z 18
Tytuł :
Profile of Enterobacteria Resistant to Beta-Lactams.
Autorzy :
Santos AL; Institute of Tropical Pathology and Public Health, Federal University of Goiás, 235 Street, Goiânia 74605-050, Brazil.
Dos Santos AP; Institute of Tropical Pathology and Public Health, Federal University of Goiás, 235 Street, Goiânia 74605-050, Brazil.
Ito CRM; Institute of Tropical Pathology and Public Health, Federal University of Goiás, 235 Street, Goiânia 74605-050, Brazil.
Queiroz PHP; Institute of Tropical Pathology and Public Health, Federal University of Goiás, 235 Street, Goiânia 74605-050, Brazil.
de Almeida JA; Institute of Tropical Pathology and Public Health, Federal University of Goiás, 235 Street, Goiânia 74605-050, Brazil.
de Carvalho Júnior MAB; Institute of Tropical Pathology and Public Health, Federal University of Goiás, 235 Street, Goiânia 74605-050, Brazil.
de Oliveira CZ; Agency of Agricultural Defense of Paraná-ADAPAR, Goioerê 80035-050, Brazil.
Avelino MAG; Medicine College, Federal University of Goiás, 235 Street, Goiânia 74690-900, Brazil.
Wastowski IJ; Laranjeiras Unit, State University of Goiás, Goiânia 74705-010, Brazil.
Gomes GPLA; Department of Biology, Federal University of Tocantins, Square 109 North, NS15 Avenue, ALCNO-14-Plano Director North, Palmas 77001-090, Brazil.
Souza ACSE; Department of Biology, Pontifical Catholic University of Goiás, 1st Avenue, Goiânia 74175-120, Brazil.
Vasconcelos LSNOL; Institute of Tropical Pathology and Public Health, Federal University of Goiás, 235 Street, Goiânia 74605-050, Brazil.
Santos MO; Medicine College, Federal University of Goiás, 235 Street, Goiânia 74690-900, Brazil.
da Silva CA; Institute of Tropical Pathology and Public Health, Federal University of Goiás, 235 Street, Goiânia 74605-050, Brazil.
Carneiro LC; Institute of Tropical Pathology and Public Health, Federal University of Goiás, 235 Street, Goiânia 74605-050, Brazil.
Pokaż więcej
Źródło :
Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2020 Jul 15; Vol. 9 (7). Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Validation of the Brazilian version of the Shame and Stigma Scale (SSS-Br) for patients with head and neck cancers.
Autorzy :
Pirola WE; Post-graduate Program in Oncology, Barretos Cancer Hospital, Barretos, SP, Brazil.
Paiva BSR; Health-Related Quality of Life Research Group (GPQual), Learning and Research Institute, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
de Oliveira CZ; Health-Related Quality of Life Research Group (GPQual), Learning and Research Institute, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Education and Research, BP - A Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil.
Lucchetti G; School of Medicine, Federal University of Juiz de Fora, Brazil.
Lucchetti ALG; School of Medicine, Federal University of Juiz de Fora, Brazil.
Kissane D; Departments of Psychiatry and Palliative Care, School of Clinical Sciences at Monash Health, Monash University, Victoria, Australia.
Paiva CE; Health-Related Quality of Life Research Group (GPQual), Learning and Research Institute, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.; Department of Clinical Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Pokaż więcej
Źródło :
Palliative & supportive care [Palliat Support Care] 2020 Apr; Vol. 18 (2), pp. 186-192.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Symptom screening in paediatrics tool for screening multiple symptoms in Brazilian patients with cancer: a cross-sectional validation study.
Autorzy :
Cadamuro SA; Oncology Graduate Program and Research Group on Palliative Care and Health-Related Quality of Life (GPQual), Barretos Cancer Hospital, Barretos, Brazil.
Franco JO; Dr. Paulo Prata School of Health Sciences of Barretos and Research Group on Palliative Care and Health-Related Quality of Life (GPQual), Barretos Cancer Hospital, Barretos, Brazil.
Paiva CE; Department of Clinical Oncology and Research Group on Palliative Care and Health-Related Quality of Life (GPQual), Barretos Cancer Hospital, Barretos, Brazil.
de Oliveira CZ; Education and Research BP - A, Beneficência Portuguesa de São Paulo, São Paulo, Brazil.; Research Group on Palliative Care and Health-Related Quality of Life (GPQual), Barretos Cancer Hospital, Barretos, Brazil.
Paiva BSR; Oncology Graduate Program and Research Group on Palliative Care and Health-Related Quality of Life (GPQual), Barretos Cancer Hospital, BARRETOS, Brazil .
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2019 Aug 02; Vol. 9 (8), pp. e028149. Date of Electronic Publication: 2019 Aug 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Proxy*
Neoplasms/*diagnosis
Neoplasms/*therapy
Adolescent ; Brazil ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Humans ; Language ; Male ; Observer Variation ; Psychometrics ; Reproducibility of Results ; Symptom Assessment/methods
Czasopismo naukowe
Tytuł :
Development and validation of a prognostic nomogram for ambulatory patients with advanced cancer.
Autorzy :
Paiva CE; Department of Clinical Oncology, Barretos Cancer Hospital, Barretos, SP, Brazil.; Palliative Care and Quality of Life Research Group, Post-Graduate Program, Barretos Cancer Hospital, Barretos, SP, Brazil.; Researcher Support Center, Learning and Research Institute, Barretos Cancer Hospital, Barretos, SP, Brazil.
Paiva BSR; Palliative Care and Quality of Life Research Group, Post-Graduate Program, Barretos Cancer Hospital, Barretos, SP, Brazil.; Researcher Support Center, Learning and Research Institute, Barretos Cancer Hospital, Barretos, SP, Brazil.
de Paula Pântano N; Researcher Support Center, Learning and Research Institute, Barretos Cancer Hospital, Barretos, SP, Brazil.
Preto DD; Department of Clinical Oncology, Barretos Cancer Hospital, Barretos, SP, Brazil.
de Oliveira CZ; Palliative Care and Quality of Life Research Group, Post-Graduate Program, Barretos Cancer Hospital, Barretos, SP, Brazil.; Researcher Support Center, Learning and Research Institute, Barretos Cancer Hospital, Barretos, SP, Brazil.; Education and Research, BP - A Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil.
Yennurajalingam S; Department of Palliative Care and Rehabilitation Medicine, M.D. Anderson Cancer Center, The University of Texas, Houston, TX, USA.
Hui D; Department of Palliative Care and Rehabilitation Medicine, M.D. Anderson Cancer Center, The University of Texas, Houston, TX, USA.
Bruera E; Department of Palliative Care and Rehabilitation Medicine, M.D. Anderson Cancer Center, The University of Texas, Houston, TX, USA.
Pokaż więcej
Źródło :
Cancer medicine [Cancer Med] 2018 Jun 01. Date of Electronic Publication: 2018 Jun 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The Brazilian version of Skindex-16 is a valid and reliable instrument to assess the health-related quality of life of patients with skin diseases.
Autorzy :
Cárcano CBM; Department of Prevention, Barretos Cancer Hospital, Barretos, Brazil.; Dr. Paulo Prata School of Health Sciences (Faculdade de Ciências da Saúde Dr. Paulo Prata - FACISB), Barretos, Brazil.
de Oliveira CZ; Researcher Support Center, Barretos Cancer Hospital, Barretos, Brazil.
Paiva BSR; Researcher Support Center, Barretos Cancer Hospital, Barretos, Brazil.; Palliative Care and Health-Related Quality of Life Research Group, Barretos, Brazil.
Paiva CE; Palliative Care and Health-Related Quality of Life Research Group, Barretos, Brazil.; Department of Clinical Oncology, Barretos Cancer Hospital, Barretos, Brazil.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2018 Mar 22; Vol. 13 (3), pp. e0194492. Date of Electronic Publication: 2018 Mar 22 (Print Publication: 2018).
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Patient Health Questionnaire*
Quality of Life*
Skin Diseases/*psychology
Adult ; Brazil ; Female ; Humans ; Male ; Middle Aged ; Psychometrics ; Reproducibility of Results ; Severity of Illness Index ; Skin Diseases/diagnosis ; Time Factors ; Translations
Czasopismo naukowe
Tytuł :
The feasibility and benefit of a brief psychosocial intervention in addition to early palliative care in patients with advanced cancer to reduce depressive symptoms: a pilot randomized controlled clinical trial.
Autorzy :
do Carmo TM; Health-Related Quality of Life Research Group (GPQual), Barretos Cancer Hospital, Barretos, SP, Brazil.
Paiva BSR; Health-Related Quality of Life Research Group (GPQual), Barretos Cancer Hospital, Barretos, SP, Brazil.; Center for Research Support (NAP), Barretos Cancer Hospital, Barretos, SP, Brazil.
de Oliveira CZ; Center for Research Support (NAP), Barretos Cancer Hospital, Barretos, SP, Brazil.
Nascimento MSA; Palliative Care Department, Barretos Cancer Hospital, Barretos, SP, Brazil.
Paiva CE; Health-Related Quality of Life Research Group (GPQual), Barretos Cancer Hospital, Barretos, SP, Brazil. .; Center for Research Support (NAP), Barretos Cancer Hospital, Barretos, SP, Brazil. .; Department of Clinical Oncology, Barretos Cancer Hospital, Barretos, SP, Brazil. .; Departamento de Oncologia Clínica, Divisão de Mama e Ginecologia, Rua Antenor Duarte Vilella, 1331, Bairro Dr Paulo Prata, Barretos, SP, CEP: 14784-400, Brazil. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2017 Aug 23; Vol. 17 (1), pp. 564. Date of Electronic Publication: 2017 Aug 23.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
MeSH Terms :
Psychiatric Rehabilitation*
Depression/*etiology
Depression/*rehabilitation
Neoplasms/*complications
Adult ; Aged ; Depression/drug therapy ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Neoplasms/pathology ; Neoplasms/therapy ; Outcome Assessment, Health Care ; Palliative Care ; Pilot Projects ; Time Factors
Czasopismo naukowe
Tytuł :
Oncology E-Learning for Undergraduate. A Prospective Randomized Controlled Trial.
Autorzy :
da Costa Vieira RA; Posgraduate Oncology Program, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331, Bairro Dr Paulo Prata, Barretos, SP, CEP: 14.784.400, Brazil. .
Lopes AH; Posgraduate Oncology Program, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331, Bairro Dr Paulo Prata, Barretos, SP, CEP: 14.784.400, Brazil.; UNIFAFIBE Universitary Center, Barretos, Brazil.
Sarri AJ; Department of Physiotherapy, Barretos, Brazil.
Benedetti ZC; Jundiaí School of Medicine, Jundiaí, Brazil.
de Oliveira CZ; Biostatistics and Epidemiology Nucleous, Barretos, Brazil.
Pokaż więcej
Źródło :
Journal of cancer education : the official journal of the American Association for Cancer Education [J Cancer Educ] 2017 Jun; Vol. 32 (2), pp. 344-351.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Medical Oncology*
Education, Distance/*methods
Educational Measurement/*statistics & numerical data
Cross-Over Studies ; Female ; Humans ; Knowledge ; Male ; Physical Therapy Specialty ; Prospective Studies ; Students, Health Occupations ; Young Adult
Czasopismo naukowe
Tytuł :
Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma.
Autorzy :
Karia BTR; Laboratory for Cancer Molecular Biology, Department of Biological Sciences, Universidade Federal de Sao Paulo, Diadema, Brazil.
Zamuner FT; Laboratory for Cancer Molecular Biology, Department of Biological Sciences, Universidade Federal de Sao Paulo, Diadema, Brazil.
Carlin V; Laboratory for Cancer Molecular Biology, Department of Biological Sciences, Universidade Federal de Sao Paulo, Diadema, Brazil.
de Oliveira CZ; Biostatistics Department, PIO XII Foundation, Hospital de Cancer de Barretos, Barretos, Brazil.; Education and Research BP - A Beneficencia Portuguesa de São Paulo, Sao Paulo, Brazil.
Carvalho AL; Department of Head and Neck Surgery, PIO XII Foundation, Hospital de Cancer de Barretos, Barretos, Brazil.
Vettore AL; Laboratory for Cancer Molecular Biology, Department of Biological Sciences, Universidade Federal de Sao Paulo, Diadema, Brazil.
Pokaż więcej
Źródło :
Current molecular medicine [Curr Mol Med] 2017; Vol. 17 (10), pp. 707-717.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigens, Neoplasm/*metabolism
Biomarkers, Tumor/*metabolism
Carcinoma, Squamous Cell/*secondary
Head and Neck Neoplasms/*pathology
Neoplasm Proteins/*metabolism
Adult ; Aged ; Aged, 80 and over ; Antigens, Neoplasm/genetics ; Biomarkers, Tumor/genetics ; Carcinoma, Squamous Cell/metabolism ; Carcinoma, Squamous Cell/surgery ; Female ; Follow-Up Studies ; Gene Expression Regulation, Neoplastic ; Head and Neck Neoplasms/metabolism ; Head and Neck Neoplasms/surgery ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Proteins/genetics ; Prognosis ; Survival Rate
Czasopismo naukowe
Tytuł :
High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients.
Autorzy :
Uzan VR; Pediatric Oncology Laboratory, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil.
Lengert Av; Pediatric Oncology Laboratory, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil.
Boldrini É; Barretos Children's Cancer Hospital, Barretos, SP, Brazil.
Penna V; Department of Orthopedic Surgery, Barretos Cancer Hospital, Barretos, SP, Brazil.
Scapulatempo-Neto C; Pediatric Oncology Laboratory, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil.; Department of Pathology, Barretos Cancer Hospital, Barretos, SP, Brazil.
Scrideli CA; Department of Pediatrics, Medicine School of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Filho AP; Department of Radiology, Barretos Cancer Hospital, Barretos, SP, Brazil.
Cavalcante CE; Department of Radiology, Barretos Children's Cancer Hospital, Barretos, SP, Brazil.
de Oliveira CZ; Center for Research Support (NAP), Barretos Cancer Hospital, Barretos, SP, Brazil.
Lopes LF; Barretos Children's Cancer Hospital, Barretos, SP, Brazil.
Vidal DO; Pediatric Oncology Laboratory, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2016 Jun 02; Vol. 11 (6), pp. e0156774. Date of Electronic Publication: 2016 Jun 02 (Print Publication: 2016).
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Osteosarcoma/*genetics
RNA, Long Noncoding/*genetics
Child ; Disease-Free Survival ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Osteosarcoma/pathology ; Prognosis ; Proportional Hazards Models ; RNA, Long Noncoding/metabolism ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Autorzy :
Lopes LF; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil. .
Macedo CR; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Aguiar Sdos S; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Barreto JH; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Martins GE; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Sonaglio V; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Milone M; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Lima ER; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Almeida MT; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Lopes PM; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Watanabe FM; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
D'Andrea ML; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Pianovski MA; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Melaragno R; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Vianna SM; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Moreira ME; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Bruniera P; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
de Oliveira CZ; Luiz Fernando Lopes, Brazilian Society of Pediatric Oncology; Carla Renata Pacheco Donato Macedo, Instituto de Oncologia Pediatrica-GRAACC, Universidade Federal de São Paulo; Viviane Sonaglio, Hospital A.C. Camargo; Maria Teresa de Assis Almeida, Universidade de São Paulo, ITACI FMUSP; Maria Lydia Mello D'Andrea, Hospital Infantil Darcy Vargas; Renato Melaragno, Hospital Santa Marcelina; Sonia Maria Rossi Vianna, Hospital do Servidor Publico Estadual; Paula Bruniera, Santa Casa de Misericordia de São Paulo, São Paulo; Luiz Fernando Lopes and Gisele Eiras Martins, Hospital de Cancer Infanto Juvenil de Barretos; Cleyton Zanardo de Oliveira, Hospital de Cancer de Barretos, Barretos; Simone dos Santos Aguiar, Centro Infantil Boldrini & CIPED/FCM/Unicamp, Campinas; Marcelo Milone, Centro de Tratamento Fabiana Macedo de Morais/GACC, São Jose dos Campos; Jose Henrique S. Barreto, Hospital São Rafael/ONCO Bahia, Salvador; Eduardo Ribeiro Lima, Hospital da Baleia, Belo Horizonte; Paula Maria Azevedo Allemand Lopes, Hospital da Criança de Brasilia Jose Alencar, Brasilia; Flora Mitie Watanabe, Hospital Infantil Pequeno Principe; Mara Albonei Pianovski, Hospital Erasto Gaertner, Curitiba; and Mauber Eduardo Schultz Moreira, Hospital Universitario de Santa Maria, Santa Maria, Brazil.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Feb 20; Vol. 34 (6), pp. 603-10. Date of Electronic Publication: 2016 Jan 04.
Typ publikacji :
Journal Article
MeSH Terms :
Bleomycin*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Cisplatin/*administration & dosage
Head and Neck Neoplasms/*drug therapy
Mediastinal Neoplasms/*drug therapy
Neoplasms, Germ Cell and Embryonal/*drug therapy
Ovarian Neoplasms/*drug therapy
Retroperitoneal Neoplasms/*drug therapy
Testicular Neoplasms/*drug therapy
Vaginal Neoplasms/*drug therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Brazil ; Child ; Disease-Free Survival ; Etoposide/administration & dosage ; Female ; Humans ; Ifosfamide/administration & dosage ; Male ; Neoplasms, Germ Cell and Embryonal/pathology ; Risk Assessment ; Survival Rate ; Vinblastine/administration & dosage
Czasopismo naukowe
Tytuł :
Risk Factors for Arm Lymphedema in a Cohort of Breast Cancer Patients Followed up for 10 Years.
Autorzy :
Vieira RA; Mastology and Breast Reconstruction Department, Barretos Cancer Hospital, Pio XII Foundation, Barretos, Brazil.
da Costa AM; Hospital-based Cancer Registry, Barretos Cancer Hospital, Pio XII Foundation, Barretos, Brazil.
de Souza JL; Mastology and Breast Reconstruction Department, Barretos Cancer Hospital, Pio XII Foundation, Barretos, Brazil.
Coelho RR; Department of Physiotherapy, Barretos Cancer Hospital, Pio XII Foundation, Barretos, Brazil.
de Oliveira CZ; Epidemiology and Biostatistics Nucleus, Barretos Cancer Hospital, Pio XII Foundation, Barretos, Brazil.
Sarri AJ; Department of Physiotherapy, Barretos Cancer Hospital, Pio XII Foundation, Barretos, Brazil.
Junior RJ; Department of Radiotherapy, Barretos Cancer Hospital, Pio XII Foundation, Barretos, Brazil.
Zucca-Matthes G; Mastology and Breast Reconstruction Department, Barretos Cancer Hospital, Pio XII Foundation, Barretos, Brazil.
Pokaż więcej
Źródło :
Breast care (Basel, Switzerland) [Breast Care (Basel)] 2016 Feb; Vol. 11 (1), pp. 45-50. Date of Electronic Publication: 2015 Dec 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Myofascial pain syndrome after head and neck cancer treatment: Prevalence, risk factors, and influence on quality of life.
Autorzy :
Cardoso LR; Physical Therapy Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Rizzo CC; Anesthesiology Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
de Oliveira CZ; Biostatistics Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
dos Santos CR; Head and Neck Surgery Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Carvalho AL; Head and Neck Surgery Department, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Pokaż więcej
Źródło :
Head & neck [Head Neck] 2015 Dec; Vol. 37 (12), pp. 1733-7. Date of Electronic Publication: 2014 Sep 25.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Head and Neck Neoplasms*/therapy
Quality of Life*
Myofascial Pain Syndromes/*epidemiology
Myofascial Pain Syndromes/*etiology
Adult ; Aged ; Aged, 80 and over ; Brazil/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Myofascial Pain Syndromes/diagnosis ; Neck Dissection/adverse effects ; Prevalence ; Prospective Studies ; Risk Factors ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
A phase II study in advanced cancer patients to evaluate the early transition to palliative care (the PREPArE trial): protocol study for a randomized controlled trial.
Autorzy :
do Carmo TM; Palliative Care and Health-Related Quality of Life Research Group (GPQual), Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .
Paiva BS; Palliative Care and Health-Related Quality of Life Research Group (GPQual), Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .; Center for Research Support - NAP, Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .
de Siqueira MR; Palliative Care and Health-Related Quality of Life Research Group (GPQual), Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .
da Rosa Lde T; Human Sciences Institute - Psychologist Course, Universidade Paulista (UNIP), São José do Rio Preto, São Paulo, Brazil. .
de Oliveira CZ; Palliative Care and Health-Related Quality of Life Research Group (GPQual), Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .; Center for Research Support - NAP, Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .
Nascimento MS; Palliative Care Department, Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .
Paiva CE; Palliative Care and Health-Related Quality of Life Research Group (GPQual), Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .; Center for Research Support - NAP, Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .; Palliative Care Department, Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .; Department of Clinical Oncology, Barretos Cancer Hospital, Pio XII Foundation, Barretos, São Paulo, Brazil. .; Departamento de Oncologia Clínica, Divisão de Mama e Ginecologia, Rua Antenor Duarte Vilella, Bairro Dr Paulo Prata, 1331, Barretos, SP, Brazil. .
Pokaż więcej
Źródło :
Trials [Trials] 2015 Apr 12; Vol. 16, pp. 160. Date of Electronic Publication: 2015 Apr 12.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Transitional Care*
Cognitive Behavioral Therapy/*methods
Neoplasms/*therapy
Palliative Care/*methods
Adaptation, Psychological ; Adolescent ; Adult ; Aged ; Brazil ; Clinical Protocols ; Disease Progression ; Feasibility Studies ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Male ; Middle Aged ; Neoplasms/pathology ; Neoplasms/psychology ; Patient Education as Topic ; Patient Satisfaction ; Quality of Life ; Referral and Consultation ; Research Design ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence.
Autorzy :
Zamunér FT; Laboratory for Cancer Molecular Biology, Department of Biological Sciences, Federal University of São Paulo, Diadema, Brazil.
Karia BT; Laboratory for Cancer Molecular Biology, Department of Biological Sciences, Federal University of São Paulo, Diadema, Brazil.
de Oliveira CZ; Biostatistics Department, Pio XII Foundation, Barretos Cancer Hospital, Barretos, Brazil.
Santos CR; Department of Head and Neck Surgery, Pio XII Foundation, Barretos Cancer Hospital, Barretos, Brazil.
Carvalho AL; Department of Head and Neck Surgery, Pio XII Foundation, Barretos Cancer Hospital, Barretos, Brazil.
Vettore AL; Laboratory for Cancer Molecular Biology, Department of Biological Sciences, Federal University of São Paulo, Diadema, Brazil. Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore. .
Pokaż więcej
Źródło :
Molecular cancer therapeutics [Mol Cancer Ther] 2015 Mar; Vol. 14 (3), pp. 828-34. Date of Electronic Publication: 2015 Jan 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigens, Neoplasm/*genetics
Biomarkers, Tumor/*genetics
Carcinoma, Squamous Cell/*genetics
Head and Neck Neoplasms/*genetics
Neoplasm Proteins/*genetics
Neoplasm Recurrence, Local/*diagnosis
Neoplasm Recurrence, Local/*genetics
Testis/*metabolism
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/metabolism ; Case-Control Studies ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic/genetics ; Head and Neck Neoplasms/metabolism ; Humans ; Male ; Middle Aged ; Mucous Membrane/metabolism ; RNA, Messenger/genetics ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck
Czasopismo naukowe
Tytuł :
TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors.
Autorzy :
Rettori MM
de Carvalho AC
Longo AL
de Oliveira CZ
Kowalski LP
Carvalho AL
Vettore AL; Cancer Molecular Biology Laboratory, Department of Biological Sciences, Federal University of São Paulo, 04039-020, São Paulo, Brazil. .
Pokaż więcej
Źródło :
Journal of translational medicine [J Transl Med] 2013 Dec 20; Vol. 11, pp. 316. Date of Electronic Publication: 2013 Dec 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA Methylation*
Carcinoma, Squamous Cell/*genetics
Cyclin A1/*genetics
Head and Neck Neoplasms/*genetics
Neoplasms, Second Primary/*genetics
Tissue Inhibitor of Metalloproteinase-3/*genetics
Carcinoma, Squamous Cell/epidemiology ; Female ; Head and Neck Neoplasms/epidemiology ; Humans ; Incidence ; Male ; Middle Aged ; Neoplasms, Second Primary/epidemiology ; Polymerase Chain Reaction ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Ki-67 and CD100 immunohistochemical expression is associated with local recurrence and poor prognosis in soft tissue sarcomas, respectively.
Autorzy :
Campos M; Molecular Oncology Research Center, Barretos Cancer Hospital, Pio XII Foundation, Barretos 14780-000;
DE Campos SG
Ribeiro GG
Eguchi FC
Silva SR
DE Oliveira CZ
DA Costa AM
Curcelli EC
Nunes MC
Penna V
Longatto-Filho A
Pokaż więcej
Źródło :
Oncology letters [Oncol Lett] 2013 May; Vol. 5 (5), pp. 1527-1535. Date of Electronic Publication: 2013 Mar 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
Autorzy :
Rettori MM; Department of Biological Science, Federal University of São Paulo, 04039-032, São Paulo, Brazil.
de Carvalho AC
Bomfim Longo AL
de Oliveira CZ
Kowalski LP
Carvalho AL
Vettore AL
Pokaż więcej
Źródło :
Carcinogenesis [Carcinogenesis] 2013 Jan; Vol. 34 (1), pp. 20-7. Date of Electronic Publication: 2012 Oct 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA Methylation*
Carcinoma, Squamous Cell/*genetics
Head and Neck Neoplasms/*genetics
Saliva/*metabolism
Tissue Inhibitor of Metalloproteinase-3/*genetics
Carcinoma, Squamous Cell/pathology ; Female ; Head and Neck Neoplasms/pathology ; Humans ; Male ; Middle Aged ; Polymerase Chain Reaction ; Prognosis ; Recurrence
Czasopismo naukowe
Tytuł :
Thrombotic obstruction of the central venous catheter in patients undergoing hematopoietic stem cell transplantation.
Autorzy :
Arone KM; Instituto de Ensino e Pesquisa, Hospital de Câncer de Barretos, Brazil.
de Oliveira CZ
Garbin LM
dos Reis PE
Galvão CM
Silveira RC
Pokaż więcej
Źródło :
Revista latino-americana de enfermagem [Rev Lat Am Enfermagem] 2012 Jul-Aug; Vol. 20 (4), pp. 804-12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Catheterization, Central Venous/*adverse effects
Thrombosis/*etiology
Thrombosis/*therapy
Humans
Czasopismo naukowe
    Wyświetlanie 1-18 z 18

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies